Amryt Pharma (NASDAQ:AMYT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Amryt Pharma missed estimated earnings by 150.0%, reporting an EPS of $-0.05 versus an estimate of $-0.02.
Revenue was up $10.70 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 4.7% drop in the share price the next day.
Here's a look at Amryt Pharma's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.17 | 0.19 | 0.13 |
| EPS Actual | -0.07 | -0.07 | -0.04 | -0.09 |
| Revenue Estimate | 56.81M | 52.78M | 50.49M | 46.15M |
| Revenue Actual | 54.83M | 56.52M | 62.76M | 48.43M |
To track all earnings releases for Amryt Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
